Consistent with the effect of PBMT on Aβ accumulation, pathological evaluation of AD‐relevant brain areas in APP/PS1 mice revealed that mice accumulated numerous amyloid plaques throughout the brain, while the staining of diffuse plaques and fibrillar plaques showed markedly weaker immunoreactivity following PBMT treatment. Here, APP is linked to Alzheimer disease.